Literature DB >> 16588723

Strain Specificity and Production of Antibiotic Substances: VII. Production of Actinomycin by Different Actinomycetes.

S A Waksman1, W B Geiger, D M Reynolds.   

Abstract

Entities:  

Keywords:  ACTINOMYCIN; ANTIBIOTICS

Mesh：

Substances：

Year:  1946        PMID： 16588723      PMCID： PMC1078897          DOI： 10.1073/pnas.32.5.117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  2 in total

1.  Actinomyces antibioticus, a New Soil Organism Antagonistic to Pathogenic and Non-pathogenic Bacteria.

Authors:  S A Waksman; H B Woodruff
Journal:  J Bacteriol       Date:  1941-08       Impact factor: 3.490

2.  A SEARCH FOR VIRUS-INACTIVATING SUBSTANCES AMONG MICROORGANISMS.

Authors:  D Jones; F R Beaudette; W B Geiger; S A Waksman
Journal:  Science       Date:  1945-06-29       Impact factor: 47.728
  2 in total
  12 in total

1.  [Systematology of Actinomyces. II. Actinomycin forming Streptomyces].

Authors:  R CORBAZ; L ETTLINGER; W KELLERSCHIERLEIN; H ZAHNER
Journal:  Arch Mikrobiol       Date:  1957

2.  The Utilization of Carbon Compounds by Some Actinomycetales as an Aid for Species Determination.

Authors:  T G Pridham; D Gottlieb
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

3.  NOMENCLATURE OF THE ACTINOMYCINS.

Authors:  S A Waksman; E Katz; L C Vining
Journal:  Proc Natl Acad Sci U S A       Date:  1958-06       Impact factor: 11.205

4.  Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.

Authors:  Takao Shishido; Frank Wolschendorf; Alexandra Duverger; Frederic Wagner; John Kappes; Jennifer Jones; Olaf Kutsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

Review 5.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

6.  Tetracyclines: light-activated antibiotics?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Future Med Chem       Date:  2019-09-23       Impact factor: 3.808

7.  Optimization of medium composition for actinomycin X2 production by Streptomyces spp JAU4234 using response surface methodology.

Authors:  Zhi-Qiang Xiong; Xiao-Rong Tu; Guo-Quan Tu
Journal:  J Ind Microbiol Biotechnol       Date:  2008-03-18       Impact factor: 3.346

8.  Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy.

Authors:  Teresa Cruz-Bustos; Gloria González-González; Julia Morales-Sanfrutos; Alicia Megía-Fernández; Francisco Santoyo-González; Antonio Osuna
Journal:  Int J Nanomedicine       Date:  2012-12-03

9.  Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injury.

Authors:  Nguyen Mai; Sara A Knowlden; Kathleen Miller-Rhodes; Viollandi Prifti; Max Sims; Mark Grier; Mark Nelson; Marc W Halterman
Journal:  Exp Mol Pathol       Date:  2020-12-29       Impact factor: 4.401

10.  Identification and characterization of Streptomyces flavogriseus NJ-4 as a novel producer of actinomycin D and holomycin.

Authors:  Zhaohui Wei; Chao Xu; Juan Wang; Fengxia Lu; Xiaomei Bie; Zhaoxin Lu
Journal:  PeerJ       Date:  2017-07-19       Impact factor: 2.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.